For each patient scenario involving a potential or confirmed gynecologic malignancy, select the most appropriate evidence-based next step in clinical management.
- A 55-year-old postmenopausal woman with atypical glandular cells (AGC) on a routine cervical cytology screening.Colposcopy, endocervical curettage, and endometrial sampling
- A 32-year-old nulligravid woman with CIN III and positive endocervical margins following a LEEP procedure who strongly desires future fertility.Repeat cervical conization procedure
- A 66-year-old woman presenting with new-onset ascites, early satiety, and a 9-cm complex solid-cystic adnexal mass with nodularity.Exploratory laparotomy for surgical staging and tumor cytoreduction
- A 26-year-old primigravida at 18 weeks gestation with a routine cervical cytology test demonstrating high-grade squamous intraepithelial lesion (HSIL).Colposcopy with targeted biopsy only, strictly deferring endocervical sampling
- A 48-year-old woman presenting with postcoital bleeding and a 4-cm visible, friable cervical mass confirmed as invasive squamous cell carcinoma on punch biopsy.Clinical and radiological staging to determine surgical versus chemoradiation candidacy
Answer
The correct matches align specific gynecologic oncology presentations with their guideline-directed clinical, diagnostic, or surgical interventions.
Each correct pair reflects ACOG and SGO standards of care. AGC requires comprehensive upper and lower genital tract sampling. Positive CIN III margins in a fertility-sparing context require re-excision. Suspected advanced ovarian cancer mandates primary surgical staging without prior biopsy. Pregnant patients with severe dysplasia undergo colposcopy without invasive endocervical sampling. Finally, bulky cervical cancer requires thorough imaging to triage between surgery and chemoradiation.
Step-by-Step Solution
Key Concept
Guideline-directed diagnostic algorithms and management strategies for gynecologic neoplasia.